This webinar takes a look at best practice as it applies to prescribing (or not prescribing) psychotropic medications for a person in recovery with both a mental illness and substance abuse (MISA) diagnosis. Each medication class will be discussed in terms of benefits and side effects and, whenever possible, recommendations of one medication type over another for the dually-diagnosed consumer. Introductory material relating to the neuroanatomy and physiology of the central nervous system will also be presented and linked to why some medications should be prescribed and why others should be avoided for this problem.

For mo0re information and registration: click here